Perhaps PD-L1 positivity, represented by TPS, could serve as a reliable biomarker for SHR-1701 plus AG regimen in pancreatic ductal adenocarcinoma. The gene discussed is CD274; the disease is pancreatic ductal adenocarcinoma.